Artikel von Dr. Philip Bußmann

Dr. Philip Bußmann has been interested in the stock market since the late 1990s, when stock prices rose tremendously and then fell even more sharply a few years later. It has now become his passion. He was curious whether the stock market really consists of 90% psychology, as the experienced stock trader Kostolany once wrote. In addition to an intensive examination of the respective investment, it requires imagination and intuition, which Kostolany claimed were lacking in traditional economists. Kostolany's statements inspired him to pursue research as a research assistant after his studies in the field at the University of Osnabrück. There, he earned his doctorate on the topic "Utilization of Information Inefficiencies for Time Series Forecasts in the Credit Default Swap Market." The insights gained were successfully applied in practice, allowing him to work as a freelancer trader after his doctorate in 2015. Through the social trading platform wikifolio, millions of euros are now invested in his investment strategies Investment 4.0 and China Hightech. Since October 2022, he has been sharing his experiences and insights as the Editor-in-Chief for the Traderfox stock magazine Growth.

Latest from Dr. Philip Bußmann

LendingClub: From bet to Certainty

From turnaround to reevaluation: LendingClub is being reclassified by the market – faster than many...

Goldman Sachs Significantly Raises the Price Target for Novo Nordisk – Wegovy Pill Comes into Focus

Goldman Sachs provides fresh buying arguments for Novo Nordisk. The US investment bank has significantly...

VW Stock: Why New Momentum is Possible Now

The E-car bonus for 2026 (up to €6,000, retroactive from 01.01.2026, application starting...

Rambus Unleashed: Why the {[“Second Tier”]} of the AI Revolution is Now Taking Over

12% Gain thanks to "Memory Wall":  Rambus reaches new highs as investors recognize the chip specialist...

Intel Reports Earnings: Investors bet on the Foundry Progress and Apple Speculation

From Rescue Case to Momentum Trade: Just before the quarterly numbers, Intel's stock is experiencing...

Baidu: AI Monopoly at a Discount Price

For me, Baidu is currently a smart "hedge" against the tariff chaos in the West. While US and EU stocks...

The Laughing Party in the Trade war: how ACM Research Benefits from China's Chip Crisis

Paradoxical beneficiary of sanctions: The stronger the US restricts high-tech exports to China, the...

Guggenheim Declares Oracle the "Investment of the Decade"

Despite the recent decline in Oracle's stock price, the analysis firm Guggenheim firmly maintains its...

Micron Technology: The Indispensable AI Engine Defies the Market

Immune Strength through Scarcity: While political turmoil weighs on the indices, Micron shines as...

3-Billion Injection for Electric Cars: Is the Rally now Starting for VW & Co.?

The federal government is launching a new funding program for private buyers and lessees of new electric...

Daily Journal Corp: Software Growth Meets Leveraged Bank Portfolio

GovTech growth: Journal Technologies is growing rapidly (2025: +32%) and is establishing stable, recurring...

Novo Nordisk: The "Pill Effect" Takes off – my top Pick Delivers!

My defensive growth favorite is fully showcasing its strengths: The stock is up almost 20% since the...

Primoris Services: The Infrastructure Winner of the Trump Doctrine

Trump's "energy dominance" meets AI hunger: The aggressive deregulation of pipelines and power plants...

AI Power Rally: These US Utilities Would Be the Biggest Beneficiaries of Trump's Auction Plan

The US utility sector may be on the verge of the most fundamental change in its financing structure in...

Needham as a Catalyst: LightPath Becomes a Defense Story

The China break: How LightPath is breaking the Germanium monopoly from the East with its patented...

Chevron Nears License Upgrade: Washington Pulls Venezuelan Oil from China's Grip

The geopolitical turning point and the restructuring of oil flows The global energy landscape is undergoing...

Krystal Biotech: Investment Hypothesis Confirmed - The Platform Proof has been Established

In my previous analyses, I have already highlighted Krystal Biotech (KRYS) in detail. At that time, the...

Salesforce Crash: When the AI Partner Becomes a Threat – why Professionals are now Taking Action

It was a Tuesday to forget for shareholders of Salesforce. With a massive drop of around 7 percent, the...

Array Technologies: Market Leader at a Discount Price – a bet on America's Energy Transition and the end of Grid Delays

The new driver: New management and analyst upgrades (TD Cowen: "Buy") create momentum. The valuation:...

Court Halts Trump's Wind Power Blockade: Ørsted Stock on the Rise

It is a setback for the Trump administration in court: A U.S. federal judge has suspended the "Stop-Work-Order"...